Annovis Bio Inc
(ANVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,841 | 9,763 | 11,121 | 2 | 0 |
| Receivables | 425 | 199 | 38 | 735 | 0 |
| TOTAL | $9,402 | $10,201 | $11,441 | $748 | $0 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 370 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $370 | $N/A |
| Total Assets | $9,402 | $10,201 | $11,441 | $1,117 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 140 | 124 | 55 | 1,234 | 0 |
| Accrued Expenses | 141 | 579 | 695 | 777 | 0 |
| TOTAL | $281 | $703 | $749 | $2,011 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 7,577 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $7,683 | $N/A |
| Total Liabilities | $281 | $703 | $749 | $9,694 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,892 | 6,867 | 6,860 | N/A | N/A |
| Common Shares | 1 | 1 | 1 | 0 | 0 |
| Retained earnings | -12,535 | -11,528 | -9,219 | -8,777 | 0 |
| TOTAL | $9,121 | $9,498 | $10,692 | $-8,576 | $0 |
| Total Liabilities And Equity | $9,402 | $10,201 | $11,441 | $1,117 | $0 |